Related Experiment Video
Updated: Aug 20, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Recent developments in the management of invasive fungal infections in patients with hematological malignancies
Meinolf Karthaus1, Oliver A Cornely
1Medizinische Klinik II, Evangelisches Johannes-Krankenhaus, Schildescher Strasse 99, 33611 Bielefeld, Germany. Meinolf-Karthaus@johanneswerk.de
Abstract:
Despite recent advances in the last decade, invasive fungal infections are still associated with a high morbidity and mortality. Invasive fungal infections constitute severe infectious complications in patients with hematological malignancies receiving myelosuppressive chemotherapy or sustained immunosuppression after allogeneic transplant regimens. Following a long period of stagnation, considerable progress has been made during the last 5 years in non-culture-based diagnostics and in the treatment of invasive fungal infections. This review highlights recent developments in the epidemiology, diagnosis, and treatment in the context of state-of-the-art management of invasive fungal infections in cancer patients.
Insights
Invasive fungal infections remain a significant threat to cancer patients, but recent advances in diagnostics and treatment offer improved outcomes. This review covers the latest developments in managing these infections in immunocompromised individuals.
Area of Science:
- Infectious Diseases
- Hematology
- Oncology
Background:
- Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in cancer patients, particularly those with hematological malignancies or undergoing transplantation.
- Despite advances, IFIs pose severe infectious complications in immunocompromised patient populations.
Purpose of the Study:
- To review recent developments in the epidemiology, diagnosis, and treatment of invasive fungal infections.
- To highlight state-of-the-art management strategies for IFIs in cancer patients.
Main Methods:
- Literature review focusing on advancements in the last five years.
- Analysis of non-culture-based diagnostic methods and therapeutic interventions for IFIs.
Main Results:
- Significant progress has been made in non-culture-based diagnostics for IFIs.
- New treatment strategies have emerged, improving the management of invasive fungal infections.
Conclusions:
- Recent advancements have improved the diagnosis and treatment of invasive fungal infections in cancer patients.
- State-of-the-art management strategies are crucial for reducing morbidity and mortality associated with IFIs.
More Related Videos
Related Concept Videos
Cryptococcal Meningitis
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

